HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Galectin isolated from parasite inhibits remission of experimental autoimmune encephalomyelitis by up-regulating autoantibody.

Abstract
Recently, parasite infections or parasite-derived products have been suggested as a therapeutic strategy with suppression of immunopathology, which involves the induction of regulatory T cells or/and T helper type 2 (Th2) responses. In a recent study, researchers reported that constructed recombinant galectin (rTl-gal) isolated from an adult worm of the gastrointestinal nematode parasite Toxascaris leonina attenuated clinical symptoms of inflammatory bowel disease in mice treated with dextran sulphate sodium. Noting the role of rTl-gal in inflammatory disease, we attempted to investigate the effect of the parasite via its rTl-gal on neuronal autoimmune disease using experimental autoimmune encephalomyelitis (EAE), a mouse inflammatory and demyelinating autoimmune disease model of human multiple sclerosis. In this model, rTl-gal-treated experimental autoimmune encephalomyelitis (EAE) mice failed to recover after the peak of the disease, leading to persistent central nervous system (CNS) damage, such as demyelination, gliosis and axonal damage. Further, rTl-gal-treated EAE mice markedly increased the number of CD45R/B220(+) B cells in both infiltrated inflammation and the periphery, along with the increased production of autoantibody [anti-myelin oligodendrocyte glycoprotein (MOG)35-55 ] in serum at chronic stage. Upon antigen restimulation, rTl-gal treatment affected the release of overall cytokines, especially interferon (IFN)-γ and tumour necrosis factor (TNF)-α. Our results suggest that galectin isolated from a gastrointestinal parasite can deliver a harmful effect to EAE contrary to its beneficial effect on inflammatory bowel disease.
AuthorsS J Bing, D Ha, G Ahn, J Cho, A Kim, S K Park, H S Yu, Y Jee
JournalClinical and experimental immunology (Clin Exp Immunol) Vol. 180 Issue 3 Pg. 419-31 (Jun 2015) ISSN: 1365-2249 [Electronic] England
PMID25619397 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 British Society for Immunology.
Chemical References
  • Autoantibodies
  • Cytokines
  • Galectins
  • Myelin-Oligodendrocyte Glycoprotein
  • Peptide Fragments
  • myelin oligodendrocyte glycoprotein (35-55)
  • Leukocyte Common Antigens
Topics
  • Animals
  • Autoantibodies (blood, immunology)
  • Axons (immunology, metabolism, pathology)
  • B-Lymphocyte Subsets (immunology, metabolism)
  • Cytokines (biosynthesis)
  • Demyelinating Diseases (immunology, pathology)
  • Disease Models, Animal
  • Disease Progression
  • Encephalomyelitis, Autoimmune, Experimental (diagnosis, immunology)
  • Female
  • Galectins (adverse effects, immunology, isolation & purification)
  • Gliosis (immunology, metabolism, pathology)
  • Immunomodulation (drug effects)
  • Leukocyte Common Antigens (metabolism)
  • Mice
  • Myelin-Oligodendrocyte Glycoprotein (adverse effects, immunology)
  • Parasites (chemistry)
  • Peptide Fragments (adverse effects, immunology)
  • Severity of Illness Index
  • Spinal Cord (immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: